monjuvi.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: * Allow: / Disallow: /pdf/Social-Media-Community-Guidelines.pdf Sitemap:
Meta Tags
Title MONJUVI® (tafasitamab-cxix) 200mg: Treatment for R/R DLBCL | Official Patient
Description See how MONJUVI may help if your DLBCL came back or did not respond to the first MONJUVI® (tafasitamab-cxix) for relapsed/refractory (R/R) DLBCL is a 200mg injection for intravenous use. Download the Dr. Discussion Guide. Please see the full Prescribing Information including Patient Information for additional Important Safety
Keywords N/A
Server Information
WebSite monjuvi faviconmonjuvi.com
Host IP 40.71.11.143
Location United States
Related Websites
Site Rank
More to Explore
monjuvi.com Valuation
US$16,147,655
Last updated: 2023-04-28 00:34:52

monjuvi.com has Semrush global rank of 655,470. monjuvi.com has an estimated worth of US$ 16,147,655, based on its estimated Ads revenue. monjuvi.com receives approximately 1,863,191 unique visitors each day. Its web server is located in United States, with IP address 40.71.11.143. According to SiteAdvisor, monjuvi.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$16,147,655
Daily Ads Revenue US$14,906
Monthly Ads Revenue US$447,166
Yearly Ads Revenue US$5,365,990
Daily Unique Visitors 124,213
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
monjuvi.com. A 599 IP: 40.71.11.143
monjuvi.com. NS 86400 NS Record: ns.udag.net.
monjuvi.com. NS 86400 NS Record: ns.udag.org.
monjuvi.com. NS 86400 NS Record: ns.udag.de.
monjuvi.com. MX 3600 MX Record: 20 mx02.morphosys.com.
monjuvi.com. MX 3600 MX Record: 10 mx01.morphosys.com.
monjuvi.com. TXT 600 TXT Record: D497572210F3181359685E7EA3615D5F2713BDBE95F7918D987A0E2924C60142
HtmlToTextCheckTime:2023-04-28 00:34:52
What is MONJUVI? What is MONJUVI? MONJUVI (tafasitamab-cxix) is a prescription medicine given with lenalidomide to treat adults with certain types of diffuse large B-cell lymphoma (DLBCL) that has come back (relapsed) or that did not respond to previous treatment (refractory) and who cannot receive a stem cell transplant. It is not known if MONJUVI is safe and effective in children. The approval of MONJUVI is based on a type of response rate. There is an ongoing study to confirm the clinical benefit of MONJUVI. Intended for US residents only MONJUVI Prescribing Information US Healthcare Professionals Site My MISSION Support Program Menu About MONJUVI Starting MONJUVI Treatment Tracker Treatment Considerations For Caregivers Support & Resources FAQs MONJUVI Prescribing Information US Healthcare Professionals Site My MISSION Support Program See how MONJUVI may help if your DLBCL came back or did not respond to the first treatment ABOUT MONJUVI Not an actual patient. DLBCL=diffuse large
HTTP Headers
HTTP/1.1 301 Moved Permanently
Content-Length: 0
Content-Type: text/html; charset=UTF-8
Location: https://monjuvi.com/
Date: Thu, 21 Oct 2021 03:31:33 GMT

HTTP/2 301 
content-length: 0
content-type: text/html; charset=iso-8859-1
location: https://www.monjuvi.com/
server: Apache/2.4.25 (Debian)
date: Thu, 21 Oct 2021 03:31:32 GMT

HTTP/2 200 
content-length: 0
content-type: text/html; charset=UTF-8
server: Apache/2.4.25 (Debian)
x-powered-by: PHP/7.2.2
date: Thu, 21 Oct 2021 03:31:33 GMT
monjuvi.com Whois Information
Domain Name: MONJUVI.COM
Registry Domain ID: 2257850897_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.udag.net
Registrar URL: http://www.united-domains.de
Updated Date: 2021-07-29T15:36:18Z
Creation Date: 2018-04-28T18:06:41Z
Registry Expiry Date: 2022-04-28T18:06:41Z
Registrar: United-Domains AG
Registrar IANA ID: 1408
Registrar Abuse Contact Email: abuse@united-domains.de
Registrar Abuse Contact Phone: +49.8151368670
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS.UDAG.DE
Name Server: NS.UDAG.NET
Name Server: NS.UDAG.ORG
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-09T19:54:20Z <<<